SkinCare Physicians

Category: Psoriasis

Sotyktu®, a breakthrough pill therapy for psoriasis now available

Published on Dec 15th, 2022 by Jeffrey Sobell, MD

Those suffering from psoriasis have a new reason to rejoice! The FDA has recently approved a novel medication called Sotyktu® (deucravacitinib). Unlike biologics, which are administered by injection, Sotyktu® is a pill taken once a day. Astonishingly, there hasn’t been a new oral medication available for psoriasis in almost 10 years! Sotyktu® is the first therapy in a new category of medications called selective TYK-2 inhibitors. The excitement surrounding this pill is how precisely it targets the excessive inflammation associated with psoriasis. It is believed that this explains the high clinical benefit and favorable safety profile observed in patients while … Continue reading »

What you need to know about newly approved Zoryve and Vtama psoriasis creams

Published on Aug 17th, 2022 by Jeffrey Sobell, MD

August is Psoriasis Awareness Month, also known as Psoriasis Action Month. The recognition of this event is especially sweet this year as two novel non-steroidal topical medications for psoriasis, Zoryve® and Vtama®, have just received FDA approval, which had not happened in over twenty years! Dr. Jeffrey Sobell, a Boston-based renowned expert in the field of psoriasis, shares the basics on these two novel creams. What’s exciting about Zoryve® and Vtama® Both creams appear much more effective than the 2 long-standing steroid-free psoriasis creams, calcipotriene (Dovonex) and tazarotene (Tazorac). It is also exciting that thinning of the skin, a potential … Continue reading »

Approvals begin to happen for 3 exciting treatment creams for psoriasis and eczema

Published on Sep 30th, 2021 by Jeffrey Sobell, MD

There are three highly anticipated new topical creams for the treatment of psoriasis and eczema moving through the FDA clearance process as we write this blog. Two new unique creams for psoriasis For psoriasis, there has not been a novel non-steroidal topical medication approved in over twenty years. Thus, it is exciting that two unique creams have completed late-stage testing and are being reviewed by the FDA for potential authorization to prescribe within the next year. Roflumilast cream 0.3% targets inflammation by inhibiting PDE-4*. In two large pivotal** studies, roughly 40% of patients were clear or almost clear of psoriasis … Continue reading »

Bothered by an itchy scalp? Understand the cause to know how to relieve it

Published on Aug 15th, 2019 by Laurel Morton, MD

Itch can be a persistent, annoying problem for many patients. Itchy scalp can be particularly troublesome and is sometimes accompanied with dandruff, a rash or even open sores. By understanding the most common causes of itchy scalp and possible treatments, you will be able to determine if you might start relieving your itch with over-the-counter products or if you should see your doctor for a consultation. What makes my scalp itchy? If you think about it, scalp skin is very different from skin on other parts of the body. It holds many thick hair follicles and where hair follicles grow, … Continue reading »

Novel therapy takes clearance of psoriasis to new heights

Published on Jun 13th, 2019 by Jeffrey Sobell, MD

Over the last 2 decades, SkinCare Physicians’ Dr. Jeff Sobell has experienced a progression in innovative therapies for psoriasis. Now, with the recent approval of Skyrizi (rizankizumab-rkaa), a biologic indicated for the treatment of moderate-to-severe plaque psoriasis, this progress continues. Skyrizi belongs to an exciting new class of medications called IL-23 inhibitors. These medications, given by subcutaneous injection, have gained in popularity as they offer patients the chance for high efficacy with favorable tolerability. In clinical trials with Skyrizi, the average patient’s psoriasis improved by over 50% after 1 dose, and over 90% after 2 doses. At one year after … Continue reading »

New therapies address scalp psoriasis with more success

Published on Mar 23rd, 2017 by Jeffrey Sobell, MD

Psoriasis is a common and incurable skin disorder that is characterized by red raised scaly lesions that can occur anywhere on the body. One of the most frequent, and often distressing, locations is on the scalp.   Common symptoms include intractable itch, burning, pain and excessive shedding of flaky skin.  Historically, addressing scalp psoriasis has been very challenging, as it seems to be more treatment resistant than psoriasis affecting other areas of the body.  But fortunately, recent research has identified a number of more successful therapeutic options. A majority of patients benefit from prescription topical solutions, oils or gels, but success … Continue reading »

Searching for a new way to treat psoriasis? Otezla may help

Published on Apr 12th, 2016 by Jeffrey Sobell, MD

Otezla® is the first pill FDA approved to treat psoriasis in over 15 years. Unlike previous oral medication options, Otezla® specifically reduces the inflammation associated with the disease process without affecting any internal organs such as the liver, kidneys or bone marrow. The safety of this therapy has been greatly celebrated; in fact, no routine blood testing is required. Otezla® is indicated for moderate to severe chronic plaque psoriasis as well as for psoriatic arthritis. At the Psoriasis Treatment Center at SkinCare Physicians, our providers have found Otezla® particularly helpful and attractive in a number of clinical scenarios. 8 clinical … Continue reading »

New Cosentyx® treatment can clear skin of patients with psoriasis

Published on Jun 4th, 2015 by Jeffrey Sobell, MD

While there is no cure for psoriasis, an autoimmune skin disease, the science of psoriasis therapies is evolving at a very rapid pace. The recent Cosentyx® approval heralds a new era for psoriasis treatment at SkinCare Physicians’ Psoriasis Treatment Center near Boston. Cosentyx® (secukinumab), a biologic therapy developed specifically for psoriasis, is now available for adults suffering from moderate-to-severe psoriasis. This is the first of several highly anticipated “second generation” biologics to complete rigorous testing and become available to treat this significant life-impacting disease. Cosentyx® targets interleukin-17 (IL-17), one of the key chemical hormones that are elevated in people who … Continue reading »

The heartbreak of psoriasis: Not just a cosmetic nuisance

Published on Jan 13th, 2015 by Jeffrey Sobell, MD

“If you suffer from severe psoriasis, you may want to consult with your rheumatologist and cardiologist” advises Dr. Jeffrey Sobell, a dermatologist and psoriasis specialist in Boston. Learn why. Psoriasis is a chronic and incurable disease affecting 3% of the US population.  The red scaly lesions on the skin are striking in appearance, however the manifestations of psoriasis often go much deeper, particularly for these people with more extensive psoriasis (covering more than 10 palm-sizes). In these individuals, there is an increased likelihood of several medical conditions, including arthritis and cardiovascular disease. Psoriatic arthritis is seen in up to 30% … Continue reading »

Advancements in psoriasis treatment hitting an all-time high

Published on Jan 8th, 2014 by Jeffrey Sobell, MD

Chances are that you or someone you know has psoriasis. It is an incurable, non-contagious autoimmune skin disease that affects 3 out of every 100 Americans. Thankfully, remarkable progress in the treatment of psoriasis has recently occurred and dermatologists at SkinCare Physicians can now select from a multitude of therapies available at their Psoriasis Treatment Center near Boston. Living with psoriasis is often physically and emotionally disabling. Sufferers deal with intense itching, cracking, bleeding and flaking of their skin that can interfere with sleep, relationships, work and daily functioning. Unfortunately, the psoriasis condition commonly leads to feelings of despair, hopelessness … Continue reading »

Back to top

Our Promise

Our team of renowned physicians and experienced support staff is committed to excellence in medical skin care and cosmetic procedures with a patient-centered focus for women and men in the greater Boston area and beyond.

Request a Consultation

Say goodbye to underarm sweat and odor.

miraDry® is a quick, non-surgical treatment providing immediate, long-lasting results with minimal downtime.

Learn More

miraDry model
miraDry Logo

Say goodbye to underarm sweat and odor.

miraDry® is a quick, non-surgical treatment providing immediate, long-lasting results with minimal downtime.

Learn More

Contact Us

    The form below should not be used by patients to communicate clinical questions to SkinCare Physicians. It is not a patient portal. If your message is of an urgent, clinical or confidential nature, please call us instead at 1-617-383-8201.

    Please email me news and special offers


    Physician society logos

    Chestnut Hill, MA (617) 731-1600

    SkinCare Physicians®
    1244 Boylston Street (Route 9)
    Chestnut Hill, Massachusetts 02467

    Phone: (617) 731-1600 Fax: (617) 731-1601

    Learn more about your rights and protections related to the No Surprises Act (HR133).

    Medical Website Design & Marketing
    by Etna Interactive

    SkinCare Physicians®
    1244 Boylston Street (Route 9)
    Chestnut Hill, Massachusetts 02467

    Phone: (617) 731-1600 Fax: (617) 731-1601

    Learn more about your rights and protections related to the No Surprises Act (HR133).

    Medical Website Design & Marketing by Etna Interactive

    The dermatologists and other medical professionals at SkinCare Physicians specialize in a wide range of dermatology treatments and services, including laser hair removal, laser skin treatment, hair transplant, eyelid surgery, body contouring, psoriasis, skin cancer, BOTOX® Cosmetic, fillers, and Thermage®. From their offices in Chestnut Hill, they serve Boston, Brookline, Cambridge, Newton and Wellesley.